Addendum: Liquid biopsy and multi-analyte testing guided treatment of HER2 positive periampullary adenocarcinoma with durable complete response after trastuzumab based therapy

Oncotarget. 2022 Nov 2:13:1215. doi: 10.18632/oncotarget.28296.

Authors

Rajnish Nagarkar¹, Darshana Patil², Sewanti Limaye³, Pradip Devhare², Ashwini Ghaisas², Navin Srivastava², Sachin Apurwa², Sanket Patil², Jinumary John², Zarrine Raazi², Aditya Shreenivas⁴, Janani Sambath^{5

6}, Ajay Srinivasan², Prashant Kumar^{2

5

6}, Dadasaheb Akolkar², Rajan Datar²

Affiliations

¹ HCG Manavata Cancer Centre, Nasik, Maharashtra, India.
² Datar Cancer Genetics Limited, Nasik, Maharashtra, India.
³ Kokilaben Dhirubhai Ambani Hospital and Medical Research Institute, Mumbai, Maharashtra, India.
⁴ Department of Medical Oncology, Medical College Wisconsin, WI, USA.
⁵ Institute of Bioinformatics, International Technology Park, Bangalore, Karnataka, India.
⁶ Manipal Academy of Higher Education, Manipal, Karnataka, India.

No abstract available

Publication types

Published Erratum